Items where Funder is Breast Cancer Research Action Group Leeds Cares.
BB/R000352/1
Hutchinson, SA, Websdale, A, Cioccoloni, G orcid.org/0000-0003-0102-9182 et al. (15 more authors) (2021) Liver x receptor alpha drives chemoresistance in response to side-chain hydroxycholesterols in triple negative breast cancer. Oncogene, 40. pp. 2872-2883. ISSN 0950-9232
Equipment Grant
Hutchinson, SA, Websdale, A, Cioccoloni, G orcid.org/0000-0003-0102-9182 et al. (15 more authors) (2021) Liver x receptor alpha drives chemoresistance in response to side-chain hydroxycholesterols in triple negative breast cancer. Oncogene, 40. pp. 2872-2883. ISSN 0950-9232
MC_PC_15055
Hutchinson, SA, Websdale, A, Cioccoloni, G orcid.org/0000-0003-0102-9182 et al. (15 more authors) (2021) Liver x receptor alpha drives chemoresistance in response to side-chain hydroxycholesterols in triple negative breast cancer. Oncogene, 40. pp. 2872-2883. ISSN 0950-9232
N/A
Hutchinson, SA, Websdale, A, Cioccoloni, G orcid.org/0000-0003-0102-9182 et al. (15 more authors) (2021) Liver x receptor alpha drives chemoresistance in response to side-chain hydroxycholesterols in triple negative breast cancer. Oncogene, 40. pp. 2872-2883. ISSN 0950-9232
Not Known
Hutchinson, SA, Websdale, A, Cioccoloni, G orcid.org/0000-0003-0102-9182 et al. (15 more authors) (2021) Liver x receptor alpha drives chemoresistance in response to side-chain hydroxycholesterols in triple negative breast cancer. Oncogene, 40. pp. 2872-2883. ISSN 0950-9232
Hutchinson, SA, Websdale, A, Cioccoloni, G orcid.org/0000-0003-0102-9182 et al. (15 more authors) (2021) Liver x receptor alpha drives chemoresistance in response to side-chain hydroxycholesterols in triple negative breast cancer. Oncogene, 40. pp. 2872-2883. ISSN 0950-9232
RF_MA_Oxy/PO 1605-382
Hutchinson, SA, Websdale, A, Cioccoloni, G orcid.org/0000-0003-0102-9182 et al. (15 more authors) (2021) Liver x receptor alpha drives chemoresistance in response to side-chain hydroxycholesterols in triple negative breast cancer. Oncogene, 40. pp. 2872-2883. ISSN 0950-9232